Literature DB >> 24257605

Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.

Jannick Prentoe1, Stéphanie B N Serre, Santseharay Ramirez, Alfredo Nicosia, Judith M Gottwein, Jens Bukh.   

Abstract

Hypervariable region 1 (HVR1) of envelope protein 2 (E2) of hepatitis C virus (HCV) serves important yet undefined roles in the viral life cycle. We previously showed that the viability of HVR1-deleted JFH1-based recombinants with Core-NS2 of H77 (H77(ΔHVR1), genotype 1a) and S52 (S52(ΔHVR1), genotype 3a) in Huh7.5 cells was rescued by E2 substitutions N476D/S733F and an E1 substitution, A369V, respectively; HVR1-deleted J6 (J6(ΔHVR1), genotype 2a) was fully viable. In single-cycle production assays, where HCV RNA was transfected into entry-deficient Huh7-derived S29 cells with low CD81 expression, we found no effect of HVR1 deletion on replication or particle release for H77 and S52. HCV pseudoparticle assays in Huh7.5 cells showed that HVR1 deletion decreased entry by 20- to 100-fold for H77, J6, and S52; N476D/S733F restored entry for H77(ΔHVR1), while A369V further impaired S52(ΔHVR1) entry. We investigated receptor usage by antibody blocking and receptor silencing in Huh7.5 cells, followed by inoculation of parental and HVR1-deleted HCV recombinants. Compared to parental viruses, scavenger receptor class B type I (SR-BI) dependency was decreased for H77(ΔHVR1/N476D/S733F), H77(N476D/S733F), S52(ΔHVR1/A369V), and S52(A369V), but not for J6(ΔHVR1). Low-density lipoprotein receptor (LDLr) dependency was decreased for HVR1-deleted viruses, but not for H77(N476D/S733F) and S52(A369V). Soluble LDLr neutralization revealed strong inhibition of parental HCV but limited effect against HVR1-deleted viruses. Apolipoprotein E (ApoE)-specific HCV neutralization was similar for H77, J6, and S52 viruses with and without HVR1. In conclusion, HVR1 and HVR1-related adaptive envelope mutations appeared to be involved in LDLr and SR-BI dependency, respectively. Also, LDLr served ApoE-independent but HVR1-dependent functions in HCV entry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24257605      PMCID: PMC3911595          DOI: 10.1128/JVI.02017-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

Review 1.  Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.

Authors:  H J Alter; L B Seeff
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

2.  Reconstituted discoidal ApoE-phospholipid particles are ligands for the scavenger receptor BI. The amino-terminal 1-165 domain of ApoE suffices for receptor binding.

Authors:  Xiaoping Li; Horng-Yuan Kan; Sophia Lavrentiadou; Monty Krieger; Vassilis Zannis
Journal:  J Biol Chem       Date:  2002-02-22       Impact factor: 5.157

Review 3.  Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.

Authors:  Judith M Gottwein; Jens Bukh
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

4.  CD81 is a central regulator of cellular events required for hepatitis C virus infection of human hepatocytes.

Authors:  Michela Brazzoli; Alessia Bianchi; Sara Filippini; Amy Weiner; Qing Zhu; Mariagrazia Pizza; Stefania Crotta
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

5.  The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

Authors:  Elisa Scarselli; Helenia Ansuini; Raffaele Cerino; Rosa Maria Roccasecca; Stefano Acali; Gessica Filocamo; Cinzia Traboni; Alfredo Nicosia; Riccardo Cortese; Alessandra Vitelli
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

6.  CD81 is an entry coreceptor for hepatitis C virus.

Authors:  Emmanuel G Cormier; Fay Tsamis; Francis Kajumo; Robert J Durso; Jason P Gardner; Tatjana Dragic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-03       Impact factor: 11.205

7.  Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2.

Authors:  RosaMaria Roccasecca; Helenia Ansuini; Alessandra Vitelli; Annalisa Meola; Elisa Scarselli; Stefano Acali; Monica Pezzanera; Bruno Bruni Ercole; Jane McKeating; Asutosh Yagnik; Armin Lahm; Anna Tramontano; Riccardo Cortese; Alfredo Nicosia
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

8.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

9.  Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies.

Authors:  Joe Grove; Søren Nielsen; Jin Zhong; Margaret F Bassendine; Heidi E Drummer; Peter Balfe; Jane A McKeating
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

10.  Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.

Authors:  Alexander Ploss; Matthew J Evans; Valeriya A Gaysinskaya; Maryline Panis; Hana You; Ype P de Jong; Charles M Rice
Journal:  Nature       Date:  2009-01-28       Impact factor: 49.962

View more
  30 in total

1.  Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Steven K H Foung; Mansun Law; Jens Bukh
Journal:  Hepatology       Date:  2016-08-09       Impact factor: 17.425

2.  New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

Authors:  Lucie Fénéant; Julie Potel; Catherine François; Famara Sané; Florian Douam; Sandrine Belouzard; Noémie Calland; Thibaut Vausselin; Yves Rouillé; Véronique Descamps; Thomas F Baumert; Gilles Duverlie; Dimitri Lavillette; Didier Hober; Jean Dubuisson; Czeslaw Wychowski; Laurence Cocquerel
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

3.  Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.

Authors:  Dorothea Bankwitz; Gabrielle Vieyres; Kathrin Hueging; Julia Bitzegeio; Mandy Doepke; Patrick Chhatwal; Sibylle Haid; Maria Teresa Catanese; Mirjam B Zeisel; Alfredo Nicosia; Thomas F Baumert; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

4.  Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.

Authors:  Jannick Prentoe; Rodrigo Velázquez-Moctezuma; Elias H Augestad; Andrea Galli; Richard Wang; Mansun Law; Harvey Alter; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-30       Impact factor: 11.205

Review 5.  Hepatitis C virus relies on lipoproteins for its life cycle.

Authors:  Germana Grassi; Giorgia Di Caprio; Gian Maria Fimia; Giuseppe Ippolito; Marco Tripodi; Tonino Alonzi
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

6.  Production and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.

Authors:  Christian K Mathiesen; Tanja B Jensen; Jannick Prentoe; Henrik Krarup; Alfredo Nicosia; Mansun Law; Jens Bukh; Judith M Gottwein
Journal:  Virology       Date:  2014-05-24       Impact factor: 3.616

7.  Successful anti-scavenger receptor class B type I (SR-BI) monoclonal antibody therapy in humanized mice after challenge with HCV variants with in vitro resistance to SR-BI-targeting agents.

Authors:  Koen Vercauteren; Naomi Van Den Eede; Ahmed Atef Mesalam; Sandrine Belouzard; Maria Teresa Catanese; Dorothea Bankwitz; Flossie Wong-Staal; Riccardo Cortese; Jean Dubuisson; Charles M Rice; Thomas Pietschmann; Geert Leroux-Roels; Alfredo Nicosia; Philip Meuleman
Journal:  Hepatology       Date:  2014-07-30       Impact factor: 17.425

8.  Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.

Authors:  Yi-Ping Li; Santseharay Ramirez; Lotte Mikkelsen; Jens Bukh
Journal:  J Virol       Date:  2014-10-29       Impact factor: 5.103

9.  Hepatitis C Virus Escape Studies of Human Antibody AR3A Reveal a High Barrier to Resistance and Novel Insights on Viral Antibody Evasion Mechanisms.

Authors:  Rodrigo Velázquez-Moctezuma; Andrea Galli; Mansun Law; Jens Bukh; Jannick Prentoe
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

Review 10.  Roles of lipoprotein receptors in the entry of hepatitis C virus.

Authors:  Jingya Lyu; Hitomi Imachi; Kensaku Fukunaga; Takuo Yoshimoto; Huanxiang Zhang; Koji Murao
Journal:  World J Hepatol       Date:  2015-10-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.